Prairie View, IL, United States of America

Sou-Jen Chang

This inventor holds 16 USPTO granted patents and 1 published patent application, plus 7 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Abbott Laboratories Corporation, Medivir Ab, Other. Active years: 1998-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sou-Jen Chang. Retrieved from https://idiyas.com/inventor/sou-jen-chang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 1)

% Patents Active = 43.8

CIPO Patents = 7 (Patent Applications = 7)

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 6.2

ph-index = 5

Forward Citations = 81(Granted Patents)

Location History:

Grayslake, IL (US) (1998)
Prairie View, IL (US) (2001 - 2013)

Company Filing History:

13 out of 4,190

Abbott Laboratories Corporation

1 out of 834,708

Other

patents

Years Active: 1998-2013

Loading Chart...

Areas of Expertise:

Histamine-3 Receptor Ligands

Acyclic Nucleoside Derivatives

Quinoline-Substituted Compounds

Bicyclic-Substituted Amines

Therapeutic Applications

Spirocyclopropyl Amides

Erythromycin Derivatives

Fused Bicyclic Compounds

Carbonate Derivatives

Carbamate Derivatives

Synthesis Processes

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8399468 - Octahydro-pyrrolo[3,4-B]pyrrole derivatives (2013-03-19),

2. 8273767 - Bicyclic-substituted amines as histamine-3 receptor ligands (2012-09-25),

3. 8106088 - Fused bicyclic-substituted amines as histamine-3 receptor ligands (2012-01-31),

4. 7932245 - Spirocyclopropyl amides and acids and their therapeutic applications (2011-04-26),

5. 7807697 - Fused bicyclic-substituted amines as histamine-3 receptor ligands (2010-10-05),

6. 7358263 - Fused bicyclic-substituted amines as histamine-3 receptor ligands (2008-04-15),

7. 7189849 - Synthesis of acyclic nucleoside derivatives (2007-03-13),

8. 7153889 - Bicyclic-substituted amines as histamine-3 receptor ligands (2006-12-26),

9. 7098222 - Bicyclic-substituted amines having cyclic-substituted monocyclic substituents (2006-08-29),

10. 7094790 - Fused bicyclic-substituted amines as histamine-3 receptor ligands (2006-08-22),

11. 7074932 - Preparation of quinoline-substituted carbonate and carbamate derivatives (2006-07-11),

12. 6605707 - Process for the preparation of 6-O-propargyl erythromycin derivatives (2003-08-12),

13. 6579986 - Preparation of quinoline-substituted carbonate and carbamate derivatives (2003-06-17),

14. 6417366 - Preparation of quinoline-substituted carbonate and carbamate derivatives (2002-07-09),

15. 6184376 - Synthesis of acyclic nucleoside derivatives (2001-02-06),

Title: An Overview of Inventor Sou-Jen Chang

Introduction

Sou-Jen Chang is a notable inventor based in Prairie View, Illinois. With a remarkable portfolio of 16 patents, Chang has made significant contributions in the field of chemistry and pharmacology, particularly focusing on compounds that can effectively target histamine receptors.

Latest Patents

Chang's latest patents include innovative compounds such as octahydro-pyrrolo[3,4-B]pyrrole derivatives. These derivatives are particularly useful in treating conditions mitigated by histamine-3 receptor ligands. The patent outlines various methods for utilizing these compounds, as well as the processes for preparing them. Additionally, his patent on bicyclic-substituted amines as histamine-3 receptor ligands describes their therapeutic potential in similar conditions. It includes the preparation of pharmaceutical compositions that incorporate these compounds, emphasizing their significance in modern medicine.

Career Highlights

Throughout his career, Sou-Jen Chang has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with Abbott Laboratories, a leader in healthcare innovation, and Mediver AB, where his scientific contributions continue to impact drug development and therapeutic strategies.

Collaborations

Collaboration has been a vital aspect of Chang's journey as an inventor. He has worked alongside distinguished colleagues, including Marlon D. Cowart and Yi-Yin Ku, who contribute to the innovative environment in which Chang thrives. Together, they have fostered substantial advancements in the field of histamine receptor research.

Conclusion

In conclusion, Sou-Jen Chang's inventive prowess and dedication to advancing pharmacological treatments highlight his significance in the field of innovation. His extensive patent portfolio reflects not only his ingenuity but also his commitment to enhancing health outcomes through scientific excellence.

Profile summary based on public USPTO records.